Coave Therapeutics Establishes New Scientific Advisory Board to Accelerate Innovation in Genetic Medicines for Eye and CNS Diseases
The SAB members include:
Olivier Danos, PhD (Chair) – Chief Scientific Officer at REGENXBIO (Rockville, MD, USA)
Dr. Danos is a pioneer in gene therapy with over 30 years of academic and industrial leadership, including roles at Biogen, Genethon and University College London, and now leads REGENXBIO's scientific strategy
Robin Ali, PhD – Professor of Human Molecular Genetics at King's College London (London, UK) and Founder of MeiraGTx
Dr. Ali is a world-leading expert in gene therapy for retinal diseases and a pioneer of translational research advancing vision restoration therapies
Aravind Asokan, PhD – Professor at Duke University School of Medicine and Director of the Danaher Beacon for Gene Therapy Innovation (Durham, NC, USA)
Dr. Asokan specializes in AAV vector biology and synthetic virology, developing engineered AAVs to enable next-generation gene therapies
Juliette Hordeaux, DVM, PhD – Chief Scientific Officer at GEMMA Biotherapeutics (Philadelphia, PA, USA) and formerly Executive Director of Translational Research at the Gene Therapy Program, University of Pennsylvania (Philadelphia, PA, USA)
Dr. Hordeaux is a recognized leader in the development of AAV-based CNS-targeted gene therapies, focused on translating preclinical innovations to clinical-stage programs
Federico Mingozzi, PhD – Chief Executive Officer of Nava Therapeutics (Philadelphia, PA, USA)
Dr. Mingozzi brings extensive expertise in gene therapy R&D and translation, having previously served as Chief Scientific Officer at Spark Therapeutics and earlier led programs at Genethon, INSERM and the Children's Hospital of Philadelphia
Amy Pooler, PhD – Senior Vice President, Research and Development at Life Edit Therapeutics (Durham, NC, USA), previously Vice President, Head of Research at Sangamo Therapeutics (Brisbane, CA, USA)
Dr. Pooler has extensive experience in translational neuroscience and genetic medicine, with leadership roles in developing CNS-targeted therapies at Sangamo and Life Edit
The SAB members will provide strategic scientific and clinical guidance to support Coave's R&D initiatives, leveraging its ALIGATER™ (Advanced Vectors-Ligand Conjugates) platform to unlock improved precision and safety in genetic medicine. Their combined expertise strengthens Coave's leadership in developing AAV-based therapeutics targeting diseases beyond the liver, including the eye and CNS.
Lolita Petit, CSO of Coave Therapeutics commented, 'We are absolutely delighted to welcome this exceptional group of world-leading experts to our Scientific Advisory Board. Their collective expertise across AAV biology, gene therapy development and translational research will be invaluable as we continue to enhance our ALIGATER™ platform and advance our therapeutic pipeline. Their support reinforces our commitment to delivering next-generation genetic medicines with improved precision and safety and accelerates our mission to transform the lives of patients with serious unmet medical needs.'
***
Photos of SAB members available on request
About ALIGATER™Coave's proprietary ALIGATER™ (Advanced Vectors-Ligand Conjugates) platform is a breakthrough technology addressing key limitations in the delivery of genetic payloads to extra-hepatic tissues, including limited tissue specificity, delivery efficiency and safety. ALIGATER™ enables conjugation of targeting ligands, such as small molecules, peptides, or antibody fragments, on AAV or non-viral vectors, offering superior delivery efficiency, tissue specificity and safety profile for a broad range of diseases. Importantly, the platform streamlines the manufacturing process by avoiding prior AAV capsid modifications. These capabilities will enable Coave to develop best-in-class gene therapies designed for specific indications.
About Coave Therapeutics Coave Therapeutics is a genetic medicine company pioneering the development of innovative solutions to enhance the precision, safety, efficacy and manufacturability of genetic medicines. With its proprietary ALIGATER™ platform, Coave is at the forefront of addressing challenges in gene therapy delivery to extra-hepatic tissues, creating a robust pipeline targeting CNS, neuromuscular and eye diseases.
Headquartered in Paris, France, Coave Therapeutics is backed by leading international life sciences investors. For more information about the science, pipeline, and people, please visit coavetx.com and follow us on LinkedIn.
CONTACTS
Coave Therapeutics Rodolphe Clerval, CEO contact@coavetx.com
MEDiSTRAVA Sylvie Berrebi, Mark Swallow coavetx@medistrava.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Tom's Guide
3 hours ago
- Tom's Guide
German Volume Training (GVT) could help you pack on muscle size and strength — here's how, according to a personal trainer
German Volume Training, or GVT, is a method that uses 10 sets and 10 reps of a compound exercise to maximize your efficiency (and gains) in the gym. With just 60 seconds between sets and as few as two exercises included per gym session, the training technique could help you pack on size pretty fast in just a matter of months. Recently, I spoke with Max Taylorson, a London-based personal trainer, who uses the method to help his clients hit their muscle mass targets with volume and overload. As a trainer myself, I had never heard of the method before, which Taylorson tells me was first used by the German national weightlifting team and later adopted by strength coach Charles Poliquin. You can certainly trust the Germans to be efficient — and this method is just that, trust me. Here's everything you need to know about GVT, including how it can help you pack on lean muscle size and take your muscles to their absolute limit. There's little room to maneuver when it comes to GVT, as you'll be rigidly sticking to 10 sets of 10 reps, taking just 60 seconds of rest between each set. Taylorson tells me you're looking to include two compound exercises in a session, like a squat and bench press. You'll lift at roughly 60-70% of your one-rep max (the maximum you can lift for that movement), and you'll know if you've hit the mark because it should feel like you could maybe achieve 15 to 20 reps at that weight. Remember, there are 10 sets to reach in total, so avoid increasing or decreasing the weight throughout your working sets. Each set will begin to feel more challenging, so keep aiming for 10 reps, if you can. Once you can comfortably hit all 10 reps for 10 sets, it's time to add weight incrementally. Doing so will help you break through plateaus and improve strength, muscle gain and endurance. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. It builds muscle quickly due to high volume. 'It builds muscle quickly due to high volume,' Taylorson explains. 'GVT uses a simple and easy-to-follow structure, which makes it easy to track progress and pushes muscles to their maximum potential, leading to growth.' Taylorson first discovered GVT for his own training regimen, having struggled to put on size previously. 'This type of program helped me increase volume,' he says. 'Focusing on big compound lifts, doing 10 sets of 10 reps, overloads the muscles. It was never time-consuming either, so great for my clients who are on a tight schedule.' Taylorson reminds me that less is more…despite the 'more is more' structure of GVT. By that, he means only pick two exercises per session. If you want to add accessory work after, you can, but only pick a couple of exercises to finish with, using a more typical weightlifting structure (so not 10 x 10). He also recommends opposing muscle groups during the session, like the lower and upper body, so that you don't overtrain a single muscle group. Try to focus on keeping movements controlled and working muscles through their full range of motion during each exercise. That means half reps don't count, and neither do rushed reps. Tempo plays into time under tension, an important part of hypertrophy, or the muscle growth process. Aim to count three to four full seconds during both phases of the movement, for example, the lowering and standing phase of a squat. Add a pause or beat at the bottom and top of the movements, too. Taylorson says programming depends on you and your workout goals, but try to train several times per week with rest days prioritized. As a trainer myself, I also recommend keeping a close eye on your form and stopping during a set before it, or you, go to absolute failure. Your results and recovery will also depend on your diet, so refueling with plenty of protein-rich foods is important. Here's how much protein you need to build muscle. An example GVT workout format: Alternate between your exercises, resting after every set. Finish with any accessory work (if you want to, this is optional), and complete as many reps of the 10 as you can. Once you manage 10 sets of 10 quite comfortably, add load. Try to stick to a program for four weeks before switching things up or mixing in new exercises. Remember, the above is only a guideline. Beginners, the German Volume Training Method may not be suitable to start your weightlifting journey with, so if you do want to try it, work closely with a personal trainer who can keep you safe and tailor your program accordingly. Follow Tom's Guide on Google News to get our up-to-date news, how-tos, and reviews in your feeds. Make sure to click the Follow button.
Atlantic
6 hours ago
- Atlantic
CDC Staffers Saw the Violence Coming
When gunfire pelted the Atlanta-based headquarters of the CDC yesterday, hundreds of employees were inside the campus's buildings. The experience was terrifying. But some of the employees were not particularly shocked. 'I'm actually surprised it didn't happen sooner,' a nearly 20-year veteran of the agency told me. (She, like others I spoke with for this article, requested anonymity out of fear of losing her job.) This was, in one sense, the first attack of its kind on the CDC. The shooter, whom law-enforcment officials have identified as Patrick Joseph White, a 30-year-old resident of an Atlanta suburb, was reportedly fixated on the idea that the COVID-19 vaccine had made him depressed and suicidal. No employees were injured by the bullets that entered the buildings, according to a CDC representative. But an Atlanta police officer named David Rose was shot and later died from his injuries. White, too, was found dead—fatally shot—at the scene. (It is not yet clear if his wound was self-inflicted or if he was killed by police.) When he took aim at the agency on Friday afternoon, he was near a corner where a lone man stands holding anti-vaccine signs nearly every day, several CDC staffers told me. In another sense, public-health workers have been facing escalating hostility since the early days of the pandemic. In 2020, armed protesters gathered on the Ohio Health Department director's front lawn, and the chief health officer of Orange County, California, was met with death threats after issuing a mask mandate. She had to hire extra security and was eventually driven to resign. Anthony Fauci, who served as the director of the National Institute of Allergy and Infectious Diseases during the country's initial COVID response, has faced regular death threats since 2020. Nearly a third of state, local, and tribal public-health workers reported facing some sort of workplace violence in a 2021 survey. Last year, Fauci told CNN's Kaitlan Collins that threats of violence to public-health workers correlate with verbal attacks from high-profile politicians and media personalities. 'It's like clockwork,' he said. In the second Trump administration, those attacks have become commonplace—the very selling points, even, that have helped a number of Trump's health appointees gain their positions. In 2024, when announcing his own pick for CDC director, President Donald Trump maligned the CDC and other federal health agencies, accusing them of having 'engaged in censorship, data manipulation, and misinformation.' Robert F. Kennedy Jr. was already a longtime anti-vaccine activist when he took the mantle as America's health secretary; he has compared vaccinating children to the abuses of the Catholic church. During his own 2024 presidential run, he promised to 'clean up the cesspool of corruption at CDC.' 'Normally, threats to public servants aren't inspired from leadership of their own organization,' another CDC staffer said in a group chat among current and former employees. According to an MSNBC report, during an all-hands meeting today, CDC staff blamed the shooting at least partly on Kennedy's combative attitude toward the agency. 'We need them to stop fanning the flames of hatred against us, stop spreading misinformation,' one employee wrote in the meeting chat, naming Kennedy in the same comment. 'We will not be safe until they stop their attacks against us.' The shooter appears to have brought five guns to the scene, and at least four federal buildings were struck by dozens of bullets. In the hours immediately after the shooting, while many CDC employees remained barricaded in offices and marooned in conference rooms, they heard nothing from Kennedy or Trump. Last night, Susan Monarez, the newly confirmed CDC director, issued a short statement reiterating the basic facts of the shooting. 'We at CDC are heartbroken by today's attack on our Roybal Campus,' she wrote. 'Our top priority is the safety and well-being of everyone at CDC.' Late this morning, Kennedy sent an email to the entire staff of the Department of Health and Human Services offering support and prayers. In a post on X at around the same time, he wrote, 'No one should face violence while working to protect the health of others.' This evening, Monarez sent a more substantial email pledging to support the CDC during its recovery and noting its resilience. 'We have faced adversity before, and we will do so again, drawing strength from our shared commitment to public health,' she wrote. The president has not yet made a statement about the attack. (The White House and HHS did not respond to requests for comment.) To the CDC employees I spoke with, the sluggish response is the latest episode in the administration's escalating abandonment of the agency. Since January, the Trump administration has hit the CDC with massive layoffs, proposed halving its budget, and forced changes to internal policies governing the fundamentals of its scientific work. Earlier this year, Kennedy purged the committee that advises the CDC on vaccine recommendations. Just this week, he canceled nearly $500 million in federally funded research on mRNA vaccines —widely considered among CDC employees and public-health experts to be the greatest domestic triumph of the U.S. pandemic response—stating incorrectly that they cause more risk than benefit against the flu and COVID. For CDC staff, the wider threat does not seem to have passed. This evening, a group of CDC employees were trading tips on peeling off their old parking decals after the agency's security office reportedly asked staff to remove them from their cars. One person suggested covering them with other stickers; another recommended loosening them with cooking oil. Even people who have volunteered for risky missions in their public-health work are still getting used to the idea that the danger has arrived at the home front. 'I've put my life on the line for this agency, responding to outbreaks in some of the most dangerous parts of the world,' a 13-year veteran of the agency told me. 'I didn't expect to face the same risks at the Atlanta campus as I faced in South Sudan.'
Time Business News
8 hours ago
- Time Business News
How Electronics Contract Manufacturer Partnerships Power Mission-Critical Applications: An Inside Look at Contract Manufacturing
In today's rapidly evolving technology landscape, over 70% of electronics companies rely on specialized partners to bring their products to market efficiently and cost-effectively. Electronics contract manufacturing has become the backbone of modern innovation, enabling everything from life-saving medical devices to mission-critical aerospace systems. Whether you're an engineering professional evaluating manufacturing options or a decision-maker exploring cost optimization strategies, understanding the intricacies of contract manufacturing can significantly impact your project's success. This comprehensive guide explores how electronics contract manufacturer partnerships work, what makes them essential for today's competitive markets, and how to leverage these relationships for maximum project success. The Basics: What is Electronics Contract Manufacturing? Electronics contract manufacturing represents a strategic partnership where specialized facilities handle the production, assembly, and testing of electronic products on behalf of original equipment manufacturers (OEMs). Think of it as having access to a fully equipped electronics factory without the massive capital investment—complete with engineering expertise, quality systems, and production capabilities. At its core, an electronics contract manufacturer serves as an extension of your engineering team. These partners bring together advanced manufacturing equipment, skilled technicians, and proven processes to transform your designs into finished products. The relationship goes far beyond simple assembly work, encompassing everything from initial design support to final product delivery. Contract manufacturing services typically include custom cable assemblies, wire harness manufacturing, box build assemblies, and precision connector solutions. This comprehensive approach allows companies to focus on their core competencies—innovation and market development—while leveraging specialized manufacturing expertise. The Manufacturing Process Behind Contract Electronics Production Design and Engineering Collaboration The contract manufacturing process begins long before production starts. Leading electronics contract manufacturer partners provide engineering support during the design phase, helping optimize products for manufacturability while maintaining performance specifications. This collaborative approach identifies potential issues early, reducing costly redesigns and accelerating time-to-market. Engineering teams work closely with clients to review designs, recommend materials, and suggest manufacturing-friendly modifications. This partnership approach ensures that custom cable assemblies and other components meet both technical requirements and production realities. Dual-Facility Manufacturing Strategy Modern contract manufacturing often employs a dual-facility approach, combining domestic and offshore capabilities to optimize cost and delivery. US-based facilities handle prototyping, engineering changes, and time-sensitive production, while offshore operations manage high-volume manufacturing runs. This strategy provides several advantages: rapid prototyping capabilities, flexibility for engineering changes, cost optimization for large volumes, and reduced supply chain risks. The key lies in seamlessly integrating both facilities to maintain quality standards and communication throughout the production process. Advanced Assembly Processes Contract manufacturing encompasses various assembly approaches, each suited to different product requirements. Wire harness manufacturing involves precision routing, connector attachment, and comprehensive testing to ensure signal integrity. Box build assemblies integrate multiple components into complete systems, requiring careful planning and quality control at each stage. For specialized applications, turnkey manufacturing services provide complete solutions from component sourcing through final testing. This comprehensive approach streamlines vendor management while ensuring consistent quality across all assembly processes. Custom Solutions and Engineering Excellence Tailored Assembly Approaches Every electronic application presents unique challenges requiring customized solutions. Medical device applications demand biocompatible materials and FDA compliance, while aerospace systems require AS9100D certification and extreme reliability standards. Industrial applications focus on durability and harsh environment performance. Successful electronics contract manufacturer partnerships adapt their processes to meet these diverse requirements. Custom cable assembly solutions might incorporate specialized materials for high-temperature applications, while precision electronics manufacturing ensures consistent performance across thousands of units. Material Selection and Quality Standards Material selection significantly impacts product performance, especially in demanding applications. Contract manufacturers maintain extensive material libraries, including various conductor types, insulation materials, and connector options. This expertise helps optimize designs for specific environmental conditions and performance requirements. Quality standards vary by industry, but leading contract manufacturers maintain multiple certifications to serve diverse markets. ISO 9001 provides foundational quality management, while AS9100D addresses aerospace-specific requirements. ITAR compliance enables defense application support, ensuring comprehensive capability across critical industries. Quality Assurance and Industry Standards Certification and Compliance Framework Quality assurance in electronics contract manufacturing extends far beyond basic testing. Comprehensive quality systems encompass design controls, process validation, and continuous improvement protocols. These systems ensure consistent results whether producing single prototypes or thousands of production units. Industry certifications provide third-party validation of quality capabilities. ISO 9001 establishes fundamental quality management principles, while industry-specific standards like AS9100D address additional requirements for aerospace applications. Medical device manufacturing requires FDA compliance and biocompatibility testing protocols. Testing Protocols and Validation Rigorous testing protocols validate both individual components and complete assemblies. Cable assembly testing includes continuity verification, insulation resistance measurement, and environmental stress screening. Box build testing encompasses functional verification, burn-in protocols, and final system integration validation. Advanced testing capabilities often include automated test equipment for high-volume production, environmental testing chambers for temperature and humidity stress, vibration testing for mechanical durability, and electromagnetic compatibility verification for regulatory compliance. Industry Applications and Market Impact Aerospace and Defense Applications Aerospace cable assembly solutions demand exceptional reliability under extreme conditions. Temperature ranges from -55°C to +200°C, vibration resistance, and electromagnetic interference shielding represent standard requirements. Mission-critical applications require additional validation through accelerated life testing and failure mode analysis. Defense applications add security considerations through ITAR compliance and domestic manufacturing requirements. These projects often involve low-volume, high-complexity assemblies requiring extensive documentation and traceability protocols. Medical Device Manufacturing Medical device cable assemblies must meet stringent biocompatibility and sterilization requirements. Materials selection considers long-term implantation safety, while manufacturing processes ensure sterile packaging and handling. FDA compliance requires comprehensive design controls and change management protocols. Contract manufacturing for medical applications often involves specialized materials like biocompatible polymers, precious metal plating for corrosion resistance, and unique connector configurations for specific medical procedures. Industrial and Energy Applications Industrial applications emphasize durability and environmental resistance. Wire harness and cable assembly solutions for energy applications must withstand temperature extremes, chemical exposure, and mechanical stress. Renewable energy applications add requirements for UV resistance and long-term outdoor exposure. High-voltage applications require specialized insulation materials and safety protocols. Contract manufacturers serving these markets maintain expertise in high-voltage design principles and testing procedures. Partnership Approach and Future Trends Strategic Manufacturing Partnerships Successful contract manufacturing relationships extend beyond simple vendor arrangements to become strategic partnerships. These relationships involve shared engineering resources, joint problem-solving initiatives, and collaborative product development efforts. Long-term partnerships enable continuous improvement through process optimization, cost reduction initiatives, and technology advancement collaboration. Regular business reviews assess performance metrics, identify improvement opportunities, and align future capacity planning with customer growth projections. Emerging Technologies and Automation The future of electronics contract manufacturing involves increasing automation and advanced technologies. Automated wire processing equipment improves consistency and reduces labor costs, while robotic assembly systems handle complex box build requirements with precision and repeatability. Industry 4.0 technologies provide real-time production monitoring, predictive maintenance capabilities, and enhanced quality tracking. These advances enable greater efficiency, improved quality control, and reduced production costs across all manufacturing processes. Market Evolution and Customer Collaboration Market trends toward miniaturization, increased functionality, and faster development cycles drive evolution in contract manufacturing capabilities. Customers increasingly value partners who provide comprehensive engineering support, rapid prototyping capabilities, and flexible production scaling. Geographic diversification continues expanding as companies seek supply chain resilience and cost optimization. Leading contract manufacturers develop global capabilities while maintaining local engineering support and customer service excellence. Conclusion Electronics contract manufacturing has evolved from simple assembly services to comprehensive partnerships that enable innovation and market success. Understanding the manufacturing process, quality requirements, and partnership benefits helps companies make informed decisions about their production strategies. The most successful projects combine technical expertise with strategic partnership approaches, leveraging specialized capabilities to achieve optimal results. As technology continues advancing and markets become increasingly competitive, these manufacturing partnerships will play even more critical roles in bringing innovative products to market efficiently and cost-effectively. For companies evaluating manufacturing options, the key lies in finding partners who understand your specific requirements, maintain appropriate certifications, and demonstrate commitment to long-term collaboration. The right electronics contract manufacturer becomes an extension of your team, contributing engineering expertise and manufacturing excellence to drive project success. TIME BUSINESS NEWS
